Mesenteric Tear after Enteroscopy- Avoidable or Inevitable
DOI:
https://doi.org/10.4103/kaj/2024/v19i1-4/169355Keywords:
No Keywords.Abstract
No Abstract.
Downloads
References
Wernli KJ, Brenner AT, Rutter CM, Inadomi JM. Risks associated with anesthesia services during colonoscopy. Gastroenterology. 2016; 150(4):888-94. quiz e18. https://doi.org/10.1053/j.gastro.2015.12.018
Cooper GS, Kou TD, Rex DK. Complications following colonoscopy with anesthesia assistance: A populationbased analysis. JAMA Intern Med. 2013; 173(7):551-6. https://doi.org/10.1001/jamainternmed.2013.2908
Ohtsuka R, Amano H, Niida K, Yoshino T, Owari M, Takano R, et al. Massive retroperitoneal hematoma following colonoscopy: A case report. Medicine (Baltimore). 2018; 97(31):e11723. https://doi.org/10.1097/MD.0000000000011723
Piccolo G, Di MV, Cavallaro A, Zanghì A, Lo EM, Cardì F, et al. Presentation and management of splenic injury after colonoscopy: A systematic review. Surg Laparosc Endosc Percutan Tech. 2014; 24(2):95-102. https://doi.org/10.1097/SLE.0b013e3182a83493
Goudra B, Singh PM, Gouda G, Borle A, Carlin A, Yadwad A. Propofol and non-propofol based sedation for outpatient colonoscopy-prospective comparison of depth of sedation using an EEG based SEDLine monitor. J Clin Monit Comput. 2015. https://doi.org/10.1007/s10877-015-9769-5
Goudra BG, Singh PM, Gouda G, Borle A, Gouda D, Dravida A, et al. Safety of non-anaesthesia provideradministered Propofol (NAAP) sedation in advanced gastrointestinal endoscopic procedures: Comparative meta-analysis of pooled results. Dig Dis Sci. 2015; 60(9):2612-27. https://doi.org/10.1007/s10620-0153608-x
Khan HA, Umar M, Tul-Bushra H, Nisar G, Bilal M, Umar S. Safety of non-anaesthesiologist-administered propofol sedation in ERCP. Arab J Gastroenterol Off Publ Pan-Arab Assoc Gastroenterol. 2014; 15(1):32-5. https://doi.org/10.1016/j.ajg.2014.01.011
Goudra B, Singh P. Remimazolam: The future of its sedative potential. Saudi J Anaesth. 2014; 8(3):388. https://doi.org/10.4103/1658-354X.136627
Fossler MJ, Sadler BM, Farrell C, Burt DA, Pitsiu M, Skobieranda F, et al. Oliceridine (TRV130), a novel G protein-biased ligand at the μ-opioid receptor, demonstrates a predictable relationship between plasma concentrations and pain relief. I: Development of a pharmacokinetic/pharmacodynamic model. J Clin Pharmacol. 2018; 58(6):750-61. https://doi.org/10.1002/jcph.1076